Mn Services Vermogensbeheer B.V. Sells 8,100 Shares of CVS Health Co. (NYSE:CVS)

Mn Services Vermogensbeheer B.V. cut its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 1.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 512,200 shares of the pharmacy operator's stock after selling 8,100 shares during the period. Mn Services Vermogensbeheer B.V.'s holdings in CVS Health were worth $30,251,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Norges Bank bought a new stake in shares of CVS Health in the 4th quarter valued at about $1,092,040,000. Capital International Investors grew its holdings in CVS Health by 47.4% during the fourth quarter. Capital International Investors now owns 33,691,698 shares of the pharmacy operator's stock valued at $2,660,298,000 after purchasing an additional 10,837,801 shares during the period. Pzena Investment Management LLC increased its stake in CVS Health by 573.8% in the first quarter. Pzena Investment Management LLC now owns 5,553,457 shares of the pharmacy operator's stock valued at $442,944,000 after purchasing an additional 4,729,207 shares in the last quarter. Capital World Investors raised its holdings in CVS Health by 8.0% in the first quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator's stock worth $3,491,643,000 after purchasing an additional 3,232,172 shares during the period. Finally, Clearbridge Investments LLC boosted its position in shares of CVS Health by 306.6% during the fourth quarter. Clearbridge Investments LLC now owns 3,046,216 shares of the pharmacy operator's stock worth $240,529,000 after purchasing an additional 2,297,100 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

Analysts Set New Price Targets

CVS has been the topic of several research analyst reports. Robert W. Baird assumed coverage on CVS Health in a research note on Thursday, May 30th. They set a "neutral" rating and a $61.00 price objective on the stock. Baird R W upgraded CVS Health to a "hold" rating in a report on Thursday, May 30th. UBS Group lowered CVS Health from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $85.00 to $60.00 in a research report on Thursday, May 2nd. Deutsche Bank Aktiengesellschaft dropped their target price on shares of CVS Health from $64.00 to $63.00 and set a "hold" rating on the stock in a report on Friday, August 9th. Finally, Leerink Partnrs downgraded shares of CVS Health from an "outperform" rating to a "market perform" rating in a research report on Wednesday, May 1st. Eleven analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $73.24.

CVS Health Stock Performance

Shares of CVS Health stock traded up $1.01 during trading on Friday, hitting $58.75. 9,614,381 shares of the stock were exchanged, compared to its average volume of 11,289,169. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The company has a fifty day moving average price of $58.86 and a 200-day moving average price of $65.09. The stock has a market capitalization of $73.75 billion, a price-to-earnings ratio of 10.33, a price-to-earnings-growth ratio of 0.57 and a beta of 0.52. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same quarter in the prior year, the company earned $2.21 earnings per share. The business's revenue for the quarter was up 2.6% compared to the same quarter last year. As a group, equities analysts predict that CVS Health Co. will post 7 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.53%. The ex-dividend date was Monday, July 22nd. CVS Health's payout ratio is presently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.